Nephros, Inc. (NEPH) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Earnings Reports
-
Nephros (NEPH) Q1 2026: Programmatic Revenue Jumps 23% as Commercial Expansion Shifts Margin Structure
May 09, 2026
-
NEPH Q4 2025: Programmatic Revenue Surpasses 90%, Anchoring Recurring Growth Model
March 13, 2026
-
PACERA Biosciences (NEPH) Q3 2025: Exparel Volumes Jump 9% as GPO Strategy Drives Access and Margin Expansion
November 07, 2025
-
NEPH (NEPH) Q2 2025: Programmatic Sales Up 40% Two-Year CAGR, Driving Recurring Revenue Strength
August 14, 2025